EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice

Philippos Koulousakis, Emily Willems, Melissa Schepers, Ben Rombaut, Jos Prickaerts, Tim Vanmierlo, Daniel van den Hove

Journal of Alzheimer’s Disease · 2023

DOI: 10.3233/jad-230657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2023. Verfasst von Philippos Koulousakis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Oxytocin, Presenilin-1. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current treatment options for Alzheimer’s disease (AD) are limited, inefficient, and often have serious side effects. Oxytocin is a neuropeptide implicated in a variety of central processes, such as social and reproductive behaviors. Among others, it has garnered attention in various domains of psychiatric research, while its role in the development and course of neurodegenerative disorders like AD is rather unknown.

Objective

This study aimed to investigate the role of exogenous oxytocin administration on memory, specifically in view of AD, as a potential novel treatment option.

Methods

We describe a novel treatment approach by using a relatively low dose of long-term intranasal oxytocin treatment, to restore memory deficits in female APPswePS1dE9 mice.

Results

Female APPswePS1dE9 mice treated with oxytocin showed increased spatial memory performance in the object location task and improved working memory in the Y-Maze, while indicating decreased sociability.

Conclusions

These results indicate that oxytocin is able to reverse acquired cognitive deficits in female APPswePS1dE9 mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesOxytocinPresenilin-1AnimalsFemaleMiceAmyloid beta-Protein PrecursorDisease Models, AnimalMaze LearningMemory DisordersMemory, Short-TermMice, Transgenic

Stichwörter der Autor:innen

APPswePS1dE9Alzheimer’s diseaseobject location taskoxytocin

Substanzen

Amyloid beta-PeptidesAmyloid beta-Protein PrecursorOxytocinPresenilin-1

Autor:innen und Institutionen

  • Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Department of Neuroscience, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.

Zitieren

APA

Koulousakis, P., Willems, E., Schepers, M., Rombaut, B., Prickaerts, J., Vanmierlo, T., & van den Hove, D. (2023). Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-230657

Vancouver

Koulousakis P, Willems E, Schepers M, Rombaut B, Prickaerts J, Vanmierlo T, et al. Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice. Journal of Alzheimer’s Disease. 2023. doi:10.3233/jad-230657

BibTeX
@article{Koulousakis2023,
  author = {Koulousakis, Philippos and Willems, Emily and Schepers, Melissa and Rombaut, Ben and Prickaerts, Jos and Vanmierlo, Tim and van den Hove, Daniel},
  title = {Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice},
  journal = {Journal of Alzheimer’s Disease},
  year = {2023},
  doi = {10.3233/jad-230657}
}
Kostenlos starten →